Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes
- PMID: 1602133
Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes
Abstract
We investigated the role of transforming growth factor-beta 1 (TGF-beta) in regulation of T cell growth and differentiation. Treatment of CTLL-2 cells with TGF-beta inhibited IL-2-dependent proliferation and caused morphologic changes as well as increased adherence. A major change of phenotype in TGF-beta-treated cells was the de novo expression of CD8 alpha chain in 35% of cells, which required the continuous presence of TGF-beta. Of the CD8 alpha+ cells, 20 to 30% co-expressed CD8 beta chain. Increased CD8 expression occurred even in the total absence of cell growth, was not a consequence of growth inhibition, and was not a result of selective growth or survival of CD8+ cells. New RNA synthesis was required for TGF beta-induced CD8 alpha surface expression, inasmuch as this was prevented by treatment with actinomycin D. Northern blot analysis demonstrated that cells treated with IL-2 + TGF-beta rapidly accumulated mRNA encoding both chains of the CD8 dimer, to a level fourfold greater than control by 6 to 12 h. In contrast, the IL-2-dependent increases in IL-2R alpha, IL-2R beta, and Granzyme B mRNA levels in these cultures were profoundly inhibited by TGF-beta. When unfractionated murine thymocytes were stimulated with phorbol dibutyrate plus ionomycin and cultured with IL-2 + TGF-beta, an increase in CD8 alpha mRNA was seen and greater numbers of CD8+ cells with higher levels of CD8 alpha and CD8 beta surface expression resulted, as compared to controls treated with IL-2 alone. Furthermore, similar treatment of CD4-CD8-(double negative) thymocytes with TGF-beta induced de novo CD8 alpha expression by a substantial number of cells, and the majority of these CD8+ cells lacked TCR/CD3. These data suggest that TGF-beta has both positive and negative regulatory effects on the expression of gene products important for T lymphocyte differentiation and function.
Similar articles
-
In vitro induction of CD8 expression on thymic pre-T cells. II. Characterization of CD3-CD4-CD8 alpha + cells generated in vitro by culturing CD25+CD3-CD4-CD8- thymocytes with T cell growth factor-beta and tumor necrosis factor-alpha.J Immunol. 1992 Jul 1;149(1):71-6. J Immunol. 1992. PMID: 1607663
-
In vitro induction of CD8 expression on thymic pre-T cells. I. Transforming growth factor-beta and tumor necrosis factor-alpha induce CD8 expression on CD8- thymic subsets including the CD25+CD3-CD4-CD8- pre-T cell subset.J Immunol. 1992 Mar 15;148(6):1737-45. J Immunol. 1992. PMID: 1347307
-
Contrasting effect of transforming growth factor type beta 1 (TGF-beta 1) on proliferation and interleukin-2 receptor expression in activated and rapidly cycling immature (CD3-CD4-CD8-) thymocytes.J Cell Physiol. 1993 Jan;154(1):44-52. doi: 10.1002/jcp.1041540107. J Cell Physiol. 1993. PMID: 8419406
-
The antiproliferative effect of kefir cell-free fraction on HuT-102 malignant T lymphocytes.Clin Lymphoma Myeloma. 2009;9 Suppl 3:S198-203. doi: 10.3816/CLM.2009.s.012. Clin Lymphoma Myeloma. 2009. PMID: 19778841 Review.
-
TGF-beta influences the life and death decisions of T lymphocytes.Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):71-9. doi: 10.1016/s1359-6101(99)00030-1. Cytokine Growth Factor Rev. 2000. PMID: 10708954 Review.
Cited by
-
Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.PLoS One. 2015 May 8;10(5):e0122387. doi: 10.1371/journal.pone.0122387. eCollection 2015. PLoS One. 2015. PMID: 25955158 Free PMC article.
-
Gammadelta T cells as immune effectors against high-grade gliomas.Immunol Res. 2009;45(1):85-95. doi: 10.1007/s12026-009-8114-9. Immunol Res. 2009. PMID: 19711198 Review.
-
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.Neuro Oncol. 2009 Aug;11(4):357-67. doi: 10.1215/15228517-2008-111. Epub 2009 Feb 11. Neuro Oncol. 2009. PMID: 19211933 Free PMC article.
-
CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.J Clin Immunol. 2009 Jul;29(4):532-44. doi: 10.1007/s10875-009-9279-7. Epub 2009 Mar 4. J Clin Immunol. 2009. PMID: 19259799
-
Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta.J Exp Med. 1994 May 1;179(5):1495-506. doi: 10.1084/jem.179.5.1495. J Exp Med. 1994. PMID: 8163934 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials